News

Monsanto ordered to pay $289 million in landmark ruling

In what’s considered a landmark ruling, the Monsanto, the makers of “Roundup” weedkiller, have been ordered to pay out $289 million to an individual in the US who claims it has contributed to his cancer. Despite this, the company has insisted that the product is safe to use. Roundup remains one of the most popular weedkiller brands even though it contains the controversial herbicide glyphosate.

Environmentalists claim that glyphosate can be linked to cancer. This has been heavily disputed by manufacturers, and, after a long drawn out legal battle, the EU has approved the chemical for use. A recent report from the WHO and the UN also said that although there is “some evidence of a positive association between glyphosate exposure and risk of non-Hodgkin’s lymphoma in some studies, the only large study of high quality found “no evidence of an association at any exposure level”.

However, in this particular case the jury ruled that the weedkiller was a “substantial factor” in the claimant, Dewayne Johnson’s, illness. They also ruled that the company had failed to properly warned its customers that the product could be dangerous. This follows the France-based International Agency for Research on Cancer’s reports that glyphosate is “probably human carcinogen”.

Mr Johnson was diagnosed with non-Hodgkin’s lymphoma four year ago. He used Monsanto products, which included Roundup and Ranger Pro, in large quantities during his years working as a school caretaker. He frequently used the products in windy conditions, meaning that they came into contact with his face. He contacted the company after developing a rash, but was never warned about the cancer risks.

Monsanto vice president Scott Partridge said the company is planning to appeal the verdict. He said that they would “vigorously defend this product” as scientific research suggests that glyphosate doesn’t cause cancer. He added: “We all have sympathy for what Mr Johnson is going through; cancer is a terrible disease. “I’ll tell you that this verdict doesn’t change the four plus decades of safe use and science behind the product. There have been over 800 medical scientific peer review published studies that have established there is no link whatsoever between glyphosate and adverse health effects, much less cancer.”

Robert Lawson

Recent Posts

Food & Beverage: Five regulatory development trends in 2024

After coming under pressure from consumers, regulations in the Food & Beverage sector are changing…

1 day ago

How the FTC and Congress plan to deal with shrinkflation

With inflation and rising living costs affecting more consumers, the issue of ‘shrinkflation’ is becoming…

6 days ago

Methylene chloride ban announced by the EPA over cancer risks

The Environmental Protection Agency (EPA) has announced a ban on methylene chloride in products for…

6 days ago

How is Ozempic affecting consumers’ food shopping habits?

Ozempic and other GLP-1 drugs are usually prescribed to treat diabetes. Recently, the endorsement of…

2 weeks ago

Dating app sued for sharing personal health information with third parties

Grindr, the world's largest dating app catering to the LGBTQ+ community, now faces legal action…

2 weeks ago

Serious illnesses reported in two US states due to fake botox injections

At least two states have seen people hospitalised with symptoms resembling botulism after undergoing cosmetic…

3 weeks ago